API Inspections

ARTICLES

Active Pharmaceutical Ingredient Process Inspections

Active pharmaceutical ingredients (APIs) are subject to the adulteration provisions of Section 501(a)(2)(B) of the Food, Drug and Cosmetic Act, which requires all drugs to be manufactured in conformance with current good manufacturing practice (CGMP). Read More